The IgG1/G2 subclass shift - a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1777-1781

  Anderhuber, W ^a   Steinschifter, W ^a   Schauenstein, E ^a   Gotschuli, A ^a   Habermann, W ^a   Fischer, M ^a   Felsner, P ^b   Schauenstein, K ^b  

^a Department of Otolaryngology ^*  (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Head neck region tumours; IgG subclasses; Squamous cell carcinoma; Tumour marker

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; TUMOR MARKER;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

EID: 0033000768     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690283     Document Type: Article

References (18)

1. Clasen B, Roettger D, Senekowitsch R and Menz E (1988) Squamous cell carcinoma antigen (SCC) - Derzeitige klinische Wertigkeit eines Tumormarkers bei Kopf-Hals-Karzinomen, Zwischenergebnisse einer prospektiven Studie nach 12 Monaten. Laryng Rhinol Otol 67: 420-425
2. Dreyfuss AI, Clark JR and Andersen JW (1992) Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen and lactic dehydrogenase level as tumor markers in squamous cell carcinoma of head and neck. Cancer 70: 2499-2503
3. Eibling CDE, Johnson JT and Wagner RL (1989) SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope 99: 117-124
4. Fischbach W, Meyer Th and Barthel K (1990) Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma. Cancer 65: 1321-1324
5. Gleich LL, Srivastava L and Gluckmann JL (1996) Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer. Ann Otol Rhinol Laryngol 105: 710-712
6. Kawano Y, Noma T and Yata J (1994) Regulation of human IgG subclass production by cytokines. IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immmunol 153: 4948-4958
7. Koch T, Eiffert H and Spindler MB (1989) Die Relevanz des neuen Tumormarkers SCC (Squamous Cell Carcinoma Antigen) für die Diagnoslik und Verlaufskontrolle von Plattenepithelkarzinomen im Kopf-Hals-Bereich. HNO 37:454-459
8. Kronberger L Jr, Weblacher M, Estelberger W, Hauser H, Schauenstein E, Schauenstein K, Smola M and Steindorfer P (1994) Pre- and postoperative analysis of serum IgG1 in patients with benign and malignant breast diseases. In 2nd European Congress on Senology, Kubista E, Staffen A and Zielinski Ch (eds) pp 479-485. Monduzzi Editore, International Proceedings Division, Bologna, Italy
9. Maninger K, Schauenstein K, Weblacher M, Tillian H, Schauenstein E (1994) Shift in IgG subclasses - a sensitive early marker for malignant proliferation in tumor bearing rats as a representative model for human cancer. Cancer Mol Biol (CMB) 1: 165-171
10. 2-induced, noncovalent self-aggregation upon storage at room temperature. Free Radical Biol Med 20: 263-270
11. Maran AGD, Wilson JA and Gaze MN (1993) The nature of head and neck cancer. Europ Arch Oto-Rhino-Laryngol 250: 127-132
12. Schauenstein E, Dachs F, Reiter M, Gombotz H and List W (1986) Labile disulfide bonds and free thiol groups in human IgG. I. Assignment to IgG1 and IgG2. Int Arch Allergy Immun 80: 174-179
13. Schauenstein E, Lahousen M, Weblacher M, Steinschifter W, Estelberger W and Schauenstein K (1996) Selective decrease in serum immunoglobulin G1 - a tissue non specific tumour marker detecting early stages of gynecological malignant diseases with high efficiency. Cancer 78: 511-516
14. Schauenstein E, Rabl H, Steinschifter W, Hirschmann C, Estelberger W and Schauenstein K (1996) Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue. Cancer 79: 1482-1486
15. Silverman NA, Alexander JC and Chretien PB (1976) CEA levels in head and neck cancer. Cancer 37: 2204-2211
16. UICC TNM (1992) Classification of malignant tumors, 4th ed, Sobin LH, Wittekind CH (eds). John Wiley & Sons Inc.: New York
17. Walther EK, Dahlmann N and Gorgulla HT (1990) Tumormarker bei Patienten mit Kopf-Hals-Karzinomen. Laryngo-Rhino-Otol 69: 271-274
18. Weblacher M, Leitsberger A, Tillian H, Maninger K, Estelberger W, Schauenstein K and Schauenstein E (1993) A decrease in reactive disulfide bonds of serum IgG signals a characteristic change in the IgG subclass pattern of rats bearing experimental tumors. Int Arch Allergy Immunol 102: 340-346